News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Increase in Deaths Linked to Common Diabetes Drugs, Cardiff University Reveals


9/27/2013 7:51:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

First-line treatment with sulfonylureas instead of metformin in people with type 2 diabetes is associated with a significantly elevated risk of death, according to results from an observational study presented at the European Association for the Study of Diabetes (EASD) meeting in Barcelona. Although guidelines do not recommend the use of sulfonylureas for first-line treatment, the drugs are still commonly prescribed this way in many countries.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes
Read at WebMD
Read at News Release

comments powered by Disqus
Forbes
WebMD
News Release
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES